D1ME100 (dengue-1 premembrane/envelope DNA vaccine)
NMRC 2004.0002
Phase 1 mab completed
Quick answer
D1ME100 (dengue-1 premembrane/envelope DNA vaccine) for Dengue is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Dengue
- Phase
- Phase 1
- Modality
- mab
- Status
- completed